arrow
A

Alfonso Mendoza-Losana

glaxosmithkline spain
H指数:19
被引数:1,452

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An assay toolkit for anti-tuberculosis drugs in the hollow fiber system

用于抗结核药物在空心纤维系统中的检测工具包

2026-04-170
OAAI
Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis

Alpibectir–Ethionamide组合(AlpE)用于治疗结核病

2026-04-070
OAAI
Sanfetrinem, an oral (3-lactam antibiotic repurposed for the treatment of tuberculosis

Sanfetrinem,一种用于治疗结核病的口服β-内酰胺类抗生素。

2025-05-010
OAAI
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis
2024-11-061
OAAI
Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes

<i>Delftia tsuruhatensis</i> TC1共生体抑制按蚊蚊子传播疟疾

Science
IF45.8
2023-01-010
OA
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis

小分子SMARt751在急性和慢性结核病小鼠模型中逆转结核分枝杆菌对乙硫酰胺的耐药性

2022-05-0419
OA
Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence
2019-03-0196
OAAI
Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening (vol 8, pg 16081, 2017)
2018-07-134
OAAI
Discovery of a Potent and Specific M-tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
2017-09-27133
PREAI